Amneal Pharmaceuticals
- Market cap
- 6.28B
- P/E (TTM)i
- 40.94
- P/Bi
- 190.78
- EPSi
- 0.22
- Div yieldi
- 0.00%
- 52W posi
- 87%
Anonymous reader poll. Unscientific, not investment advice.
Amneal Pharmaceuticals last traded at 19.65, down 3.18% on the session. At current prices, the business is worth about 6.28B, the #1854 most valuable US-listed company we track. The trailing P/E of 42.27 is 66% below its five-year average of 123.71. Wall Street's 6-analyst consensus lands on Buy, with a price target averaging 23.20 (+18% from here). Over the past year the stock has ranged from 9.56 to 21.18; it now sits 87% up that band.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 8% of the universe, above its 200-day average.
- Signal has read BUY for 6 months.
- Recent price momentum is +52.5% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 20.30
- Open
- 20.24
- Day range
- 19.53 - 20.53
- Avg price
- 19.87
- Volume
- 4.66M
- Turnover
- 92.66M
- Turnover ratei
- 2.44%
- Volume ratioi
- 1.02
- Amplitudei
- 4.93%
- 52-week rangei
- 9.56 - 21.18
Valuation
- P/Ei
- 89.32
- P/E (TTM)i
- 40.94
- P/Bi
- 190.78
- EPSi
- 0.22
- Book value / shi
- 0.10
- Net profit
- 70.26M
- Net assets
- 32.89M
Share structure
- Market cap
- 6.28B
- Float capi
- 3.75B
- Shares out
- 319.35M
- Float sharesi
- 190.89M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
7.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+2.37M net over the window
Short interest
- Shares short
- 11.29M
- % of floati
- 3.54%
- Days to coveri
- 6.64
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Amneal Pharmaceuticals (AMRX)?
Amneal Pharmaceuticals last traded at 19.65. The quote on this page refreshes every few seconds while US markets are open.
What is Amneal Pharmaceuticals's market cap?
About 6.28B.
What is the P/E ratio of Amneal Pharmaceuticals?
The trailing twelve-month P/E is 40.94, below its own 5-year average of 123.71 — in the middle of its historical range (59.14% percentile). See the Valuation tab for the full history.
Does Amneal Pharmaceuticals pay a dividend?
Amneal Pharmaceuticals does not currently pay a regular dividend.
Is Amneal Pharmaceuticals a buy according to analysts?
The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 23.20, which implies 18.1% upside from the current price. This is not investment advice.
What is Amneal Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Amneal Pharmaceuticals a B (Buy). Twelve-month momentum in the top 8% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 04:01:02 · For reference only, not investment advice and not tailored to your situation.